Published in Bioessays on February 01, 2007
Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One (2012) 1.36
The role of amygdaloid brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein and dendritic spines in anxiety and alcoholism. Addict Biol (2010) 1.10
Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia. J Abnorm Psychol (2008) 0.97
Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem (2009) 0.96
Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.93
Intense training overcomes effects of the Val66Met BDNF polymorphism on short-term plasticity. Exp Brain Res (2011) 0.89
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets. Curr Neuropharmacol (2016) 0.89
The clinical implications of mouse models of enhanced anxiety. Future Neurol (2011) 0.89
Genotyping the BDNF rs6265 (val66met) polymorphism by one-step amplified refractory mutation system PCR. Psychiatr Genet (2010) 0.85
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome. Neuropsychiatr Dis Treat (2015) 0.78
A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action. Clin Psychopharmacol Neurosci (2012) 0.78
The role of the brain-derived neurotrophic factor genotype and parenting in early life in predicting externalizing and internalizing symptoms in children with attention-deficit hyperactivity disorder. Behav Brain Funct (2014) 0.77
Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia. Neurosci Lett (2009) 0.77
Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice. Nicotine Tob Res (2015) 0.76
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS One (2017) 0.75
Serum NPY and BNDF response to a behavioral stressor in alcohol-dependent and healthy control participants. Psychopharmacology (Berl) (2011) 0.75
Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis. Transl Psychiatry (2017) 0.75
Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev (2009) 1.88
Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.23
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. Eur J Pharmacol (2005) 1.03
Glycine transporter-1: a new potential therapeutic target for schizophrenia. Curr Pharm Des (2011) 0.95
Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine. Expert Rev Neurother (2011) 0.88
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of alpha7 nicotinic receptors. Eur J Pharmacol (2006) 0.87
Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia? CNS Neurol Disord Drug Targets (2009) 0.85